Clinical trial • Phase I • Oncology
Clinical trial in Advanced solid tumors
Phase I trial for Advanced solid tumors. 143 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 31-07-2025
- First CTIS Authorization Date
- 24-11-2025
Trial design
Phase I trial across 3 sites in Spain.
- Target Sample Size
- 143
Eligibility
Recruits 143 Vulnerable population not selected; no specific consent or assent handling described in the available record..
- Vulnerable Population
- Vulnerable population not selected; no specific consent or assent handling described in the available record.
Recruitment
- Planned Sample Size
- 143
- Recruitment Window Months
- 33
- Consent Approach
- Informed consent provided by adult participants; no details on assent, age-specific documents, or languages available are provided in the record.
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 35
Spain
- Earliest CTIS Part Ii Submission Date
- 07-11-2025
- Latest Decision Or Authorization Date
- 28-01-2026
- Processing Time Days
- 82
- Number Of Sites
- 3
- Number Of Participants
- 35
Sites
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Start - Centro Integral Oncológico Clara Campal
- Contact Person Name
- Juan Jose Soto Castillo
- Contact Person Email
- juanj.soto@startmadrid.com
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Start Madrid - FJD
- Contact Person Name
- Victor Moreno Garcia
- Contact Person Email
- victor.moreno@startmadrid.com
- Site Name
- Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
- Department Name
- Oncology (VHIO)
- Contact Person Name
- Irene Braña Garcia
- Contact Person Email
- ibrana@vhio.net
Sponsor
Primary sponsor
- Full Name
- Gilead Sciences Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.